Publications by authors named "Martin Merz"

Claim this Profile
D
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.
David C Wheeler, Kevin M Pantalone, Lixin Guo, Nihar R Desai, Ricardo Correa-Rotter, Martin Merz

Clin Kidney J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting.
Susanne B Nicholas, Ricardo Correa-Rotter, Nihar R Desai, Lixin Guo, Sankar D Navaneethan, Martin Merz

J Nephrol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden of Pelvic Pain Associated With Endometriosis Among Women in Selected European Countries and the United States: A Restricted Systematic Review.
Sawsan As-Sanie, Amy L Shafrir, Lisa Halvorson, Rajinder Chawla, Rowena Hughes, Martin Merz

J Minim Invasive Gynecol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review.
Dustin Costescu, Rajinder Chawla, Rowena Hughes, Stephanie Teal, Martin Merz

BMC Womens Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
Birte Maria Hofmann, Dan Apter, Johannes Bitzer, Isabel Reinecke, Marco Serrani, Martin Merz

Eur J Contracept Reprod Health Care· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use" [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22-28].
Kristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, Thomas Faustmann, Kimberly Rosen, Martin Merz

Eur J Obstet Gynecol Reprod Biol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
Andreas D Ebert, Liying Dong, Martin Merz, Bodo Kirsch, Maja Francuski

J Pediatr Adolesc Gynecol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use.
Kristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, Thomas Faustmann, Kimberly Rosen, Martin Merz

Eur J Obstet Gynecol Reprod Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
Inka Wiegratz, Susana Bassol, Edith Weisberg, Uwe Mellinger, Martin Merz

Reprod Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
Birte Hofmann, Isabel Reinecke, Barbara Schuett, Martin Merz, Christian Zurth

Int J Clin Pharmacol Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Carolyn L Westhoff, Isabel Reinecke, Keith Bangerter, Martin Merz

Contraception· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Christoph Gerlinger, James Trussell, Uwe Mellinger, Martin Merz, Joachim Marr

Contraception· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an ethinyl estradiol/gestodene transdermal contraceptive patch on the endometrium: a single-center, uncontrolled study.
Martin Merz, Julia Grunert

Womens Health (Lond)· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study.
Wolfgang Junge, Doris Heger-Mahn, Dietmar Trummer, Martin Merz

Drugs R D· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis